{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:50:17Z","timestamp":1790427017190,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81925035"],"award-info":[{"award-number":["81925035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81521005"],"award-info":[{"award-number":["81521005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012492","name":"Youth Innovation Promotion Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.apsb.2021.09.004","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T12:19:10Z","timestamp":1631189950000},"page":"1523-1533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles"],"prefix":"10.1016","volume":"12","author":[{"given":"Canhao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7067-8915","authenticated-orcid":false,"given":"Yongzhuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.09.004_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S2468-1253(21)00076-5","article-title":"Gastrointestinal sequelae 90 days after discharge for COVID-19","volume":"6","author":"Weng","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.09.004_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2021.09.004_bib4","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2021.09.004_bib5","article-title":"Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19","volume":"2","author":"Singh","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.apsb.2021.09.004_bib6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe COVID-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.09.004_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2021.09.004_bib8","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1038\/s41467-020-18319-6","article-title":"Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.09.004_bib9","doi-asserted-by":"crossref","first-page":"e61390","DOI":"10.7554\/eLife.61390","article-title":"ACE2: evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities","volume":"9","author":"Zamorano Cuervo","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.apsb.2021.09.004_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41422-020-00450-0","article-title":"Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2021.09.004_bib11","first-page":"4","article-title":"Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development","volume":"16","author":"Zhu","year":"2021","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.apsb.2021.09.004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2021.09.004_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.apsb.2021.09.004_bib14","article-title":"The biology, function, and applications of exosomes in cancer","author":"Liu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2021.09.004_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/aps.2017.162","article-title":"Exosomes: new molecular targets of diseases","volume":"39","author":"Samanta","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2021.09.004_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.tibtech.2017.03.004","article-title":"Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges","volume":"35","author":"Syn","year":"2017","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.apsb.2021.09.004_bib17","doi-asserted-by":"crossref","first-page":"119333","DOI":"10.1016\/j.ijpharm.2020.119333","article-title":"Exosomes: from garbage bins to translational medicine","volume":"583","author":"Liu","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2021.09.004_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav8521","article-title":"Advances in therapeutic applications of extracellular vesicles","volume":"11","author":"Wiklander","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2021.09.004_bib19","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41587-020-0725-7","article-title":"Big pharma buys into exosomes for drug delivery","volume":"38","author":"Zipkin","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2021.09.004_bib20","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"30","author":"Th\u00e9ry","year":"2006","journal-title":"Curr Protoc Cell Biol"},{"key":"10.1016\/j.apsb.2021.09.004_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2021.09.004_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.gendis.2020.07.006","article-title":"Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2","volume":"7","author":"Hu","year":"2020","journal-title":"Genes Dis"},{"key":"10.1016\/j.apsb.2021.09.004_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bj.2020.06.003","article-title":"Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development","volume":"43","author":"Huang","year":"2020","journal-title":"Biomed J"},{"key":"10.1016\/j.apsb.2021.09.004_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: a vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.apsb.2021.09.004_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/cas.13488","article-title":"Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.apsb.2021.09.004_bib26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2021.09.004_bib27","doi-asserted-by":"crossref","first-page":"16413","DOI":"10.1021\/jacs.8b10047","article-title":"Reprogramming exosomes as nanoscale controllers of cellular immunity","volume":"140","author":"Cheng","year":"2018","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2021.09.004_bib28","doi-asserted-by":"crossref","first-page":"1324730","DOI":"10.1080\/20013078.2017.1324730","article-title":"Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells","volume":"6","author":"Zhu","year":"2017","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2021.09.004_bib29","doi-asserted-by":"crossref","first-page":"e1007236","DOI":"10.1371\/journal.ppat.1007236","article-title":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2","volume":"14","author":"Song","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.09.004_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.09.004_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2021.09.004_bib32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41582-020-0402-y","article-title":"Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19","volume":"16","author":"De Virgiliis","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2021.09.004_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnana.2020.00037","article-title":"Neuromechanisms of SARS-CoV-2: a review","volume":"14","author":"DosSantos","year":"2020","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.apsb.2021.09.004_bib34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12035-020-02149-0","article-title":"A Review on the neurological manifestations of COVID-19 infection: a mechanistic view","volume":"58","author":"Soltani Zangbar","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2021.09.004_bib35","article-title":"The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in\u00a0vitro and in\u00a0vivo activity against SARS-CoV-2","author":"Cathcart","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2021.09.004_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/d41586-021-00650-7","article-title":"COVID antibody treatments show promise for preventing severe disease","volume":"591","author":"Ledford","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.09.004_bib37","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood.2020008423","article-title":"Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19","volume":"136","author":"Hueso","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2021.09.004_bib38","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","article-title":"Human recombinant soluble ACE2 in severe COVID-19","volume":"8","author":"Zoufaly","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.apsb.2021.09.004_bib39","doi-asserted-by":"crossref","first-page":"C279","DOI":"10.1152\/ajpcell.00478.2020","article-title":"Soluble ACE2 as a potential therapy for COVID-19","volume":"320","author":"Krishnamurthy","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apsb.2021.09.004_bib40","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1021\/acs.nanolett.0c02278","article-title":"Cellular nanosponges inhibit SARS-CoV-2 infectivity","volume":"20","author":"Zhang","year":"2020","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2021.09.004_bib41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","article-title":"Exosome-based liquid biopsies in cancer: opportunities and challenges","volume":"32","author":"Yu","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2021.09.004_bib42","doi-asserted-by":"crossref","first-page":"120435","DOI":"10.1016\/j.biomaterials.2020.120435","article-title":"Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle","volume":"266","author":"Conceicao","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2021.09.004_bib43","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1042\/CS20200623","article-title":"Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy","volume":"134","author":"Inal","year":"2020","journal-title":"Clin Sci"},{"key":"10.1016\/j.apsb.2021.09.004_bib44","doi-asserted-by":"crossref","first-page":"e12050","DOI":"10.1002\/jev2.12050","article-title":"Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 spike protein-containing virus","volume":"10","author":"Cocozza","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2021.09.004_bib45","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.mayocp.2020.05.030","article-title":"Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis","volume":"95","author":"Agyeman","year":"2020","journal-title":"Mayo Clin Proc"}],"updated-by":[{"DOI":"10.1016\/j.apsb.2023.08.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000}}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:15:06Z","timestamp":1762604106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521003464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2211383521003464"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.09.004","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}